THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 26 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $96,000 | 0.0% | 100,000 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $96,000 | -7.7% | 100,000 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $104,000 | +14.3% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $91,000 | -29.5% | 100,000 | -33.3% | 0.01% | -28.6% |
| Q2 2019 | $129,000 | -11.0% | 150,000 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $145,000 | -5.8% | 150,000 | 0.0% | 0.01% | -10.0% |
| Q4 2018 | $154,000 | -13.0% | 150,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $177,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|